Comparison of active and combined passive/ active immunization of Navajo children against Haemophilus influenzae type b
Authors:
- G. William LetsonGLG. William Letson
- Mathuram SantoshamMSMathuram Santosham
- Raymond ReidRRRaymond Reid
- Claudette PriehsCPClaudette Priehs
- Barbara BurnsBBBarbara Burns
- Andrea JahnkeAJAndrea Jahnke
- Sheila GahaganSGSheila Gahagan
- Linus NienstadtLNLinus Nienstadt
- Cynsie JohnsonCJCynsie Johnson
- David SmithDSDavid Smith
- George SiberGSGeorge Siber
- 1 November 1988
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 7 (11) , 747-752
Abstract
In a high risk Navajo population we compared the immunogenicity of a new Haemophilus influenzae type b mutant-diphtheria toxic conjugate vaccine (HbOC) with simultaneous active (HbOC) and passive immunization with bacterial polysaccharide immunoglobulin prepared from adults immunized with H. influenzae b, pneumococcal and meningococcal vaccines. Only 7 of 26 (27%) 2-month-olds had an increase in H. influenzae b capsular polysaccharide antibody after a single dose of HbOC, a proportion similar to that of saline controls (9 of 25, 36%). After a second HbOC dose at 4 months 88% had antibody concentrations of 0.15 microgram or more, and after a third dose at 6 months all had antibody levels greater than or equal to 0.15 microgram/ml. The group receiving both HbOC and bacterial polysaccharide immunoglobulin at 2 months uniformly had H. influenzae b CP antibody concentrations of greater than or equal to 0.15 microgram/ml at 4 months (P less than 0.001 relative to "HbOC alone" group) and subsequently responded similarly to second and third doses of HbOC vaccine as did also the "HbOC alone" group. We conclude that combined passive/active immunization with bacterial polysaccharide immunoglobulin and HbOC at 2 months maintains antibody at concentrations thought to be protective (greater than or equal to 0.15 microgram/ml) without interfering with the active antibody response to second and third doses of HbOC at 4 and 6 months of age.Keywords
This publication has 5 references indexed in Scilit:
- Prevention ofHaemophilus influenzaeType b Infections in High-Risk Infants Treated with Bacterial Polysaccharide Immune GlobulinNew England Journal of Medicine, 1987
- Lack of Comparability Between Commonly Used Serological Assays of Immune Response to Haemophilus influenzae VaccineThe Journal of Infectious Diseases, 1987
- IMMUNOGENICITY IN INFANTS OF HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE IN A CONJUGATE VACCINE WITH NEISSERIA MENINGITIDIS OUTER-MEMBRANE PROTEINThe Lancet, 1986
- Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of Haemophilus influenzae type bThe Journal of Pediatrics, 1985
- ANTIBODY LEVELS ACHIEVED IN INFANTS BY COURSE OF HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE/DIPHTHERIA TOXOID CONJUGATE VACCINEThe Lancet, 1985